Skip to main navigation
Skip to search
Skip to main content
Imam Abdulrahman bin Faisal University Home
Home
Profiles
Research units
Research output
Press/Media
Search by expertise, name or affiliation
Binding Antibodies Responses to SARS-COV-2 Infection in Hospitalized Patients and Vaccinated Subjects: A Longitudinal Prospective Observational Study
Mohammed Saeed Alshahrani
*
, Razan Aldahhan
, Nabela Calamata Macadato
, Zahra Alkhalifah
, Mohamed R.El Tahan
, Amani Alnimr
, Mohammed Alabdrab Alnabi
, Fatima Almishkab
, Jawaher Almusairii
, Laila Perlas Asonto
, Sajjad Mohammed Almusawi
, Mohammed Almussalam
, Rawan Alsanea
, Mubarak Khalifa Albakheet
, Talal Ali Albrahim
, Moaz Saad Alammar
, Maan Albehair
,
Suzan A. Alkhater
,
Amal Alsulaibikh
,
Mohammed Aljumaan
Saad M. Alqahtani
, Ahmed Abdelhady, Charlene Mapusao, Ashraf Attia,
Iman Almansour Alzamil
Show 5 others
Show less
*
Corresponding author for this work
Genetic Research Department
Imam Abdulrahman Bin Faisal University
Ministry of Health, Saudi Arabia
National Guard Hospital
Alexandria University
Research output
:
Contribution to journal
›
Article
›
peer-review
1
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Binding Antibodies Responses to SARS-COV-2 Infection in Hospitalized Patients and Vaccinated Subjects: A Longitudinal Prospective Observational Study'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Immunology and Microbiology
Infection
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Severe Acute Respiratory Syndrome
100%
Antibody Response
100%
Binding Antibody
100%
COVID-19
83%
Immune Response
33%
Spike
33%
Seropositivity
33%
Dynamics
16%
Mortality Rate
16%
Prevalence
16%
Antibody Titer
16%
Titer
16%
Comorbidity
16%
Antibody Blood Level
16%
Humoral Antibody
16%
Nursing and Health Professions
Infection
100%
Severe Acute Respiratory Syndrome
100%
COVID-19
71%
Disease Severity
42%
Volunteer
42%
Spike
28%
Herd Immunity
28%
Mortality Rate
14%
Prevalence
14%
Intensive Care
14%
Antibody Titer
14%
Comorbidity
14%
Tertiary Care Center
14%
BNT162b2 vaccine
14%
Antibody Blood Level
14%
Humoral Antibody
14%
Biochemistry, Genetics and Molecular Biology
Titer
33%
Herd Immunity
33%
S1 Domain
16%